Advanced search
Add to list

Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Carlier, Charlotte, et al. “Preclinical Activity of Two Paclitaxel Nanoparticle Formulations after IP Administration in Ovarian Cancer Xenografts.” Regional Cancer Therapies, 13th International Symposium, Abstracts, 2018.
APA
Carlier, C., Hoorens, A., De Clercq, K., Giordano, S., Morosi, L., Davoli, E., … Ceelen, W. (2018). Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts. Regional Cancer Therapies, 13th International Symposium, Abstracts. Presented at the 13th International symposium on Regional Cancer Therapies (SSO 2018), Jacksonville, FL, USA.
Chicago author-date
Carlier, Charlotte, Anne Hoorens, Kaat De Clercq, Silvia Giordano, Lavinia Morosi, Enrico Davoli, Jo Van Dorpe, Chris Vervaet, Frank Vanhaecke, and Wim Ceelen. 2018. “Preclinical Activity of Two Paclitaxel Nanoparticle Formulations after IP Administration in Ovarian Cancer Xenografts.” In Regional Cancer Therapies, 13th International Symposium, Abstracts.
Chicago author-date (all authors)
Carlier, Charlotte, Anne Hoorens, Kaat De Clercq, Silvia Giordano, Lavinia Morosi, Enrico Davoli, Jo Van Dorpe, Chris Vervaet, Frank Vanhaecke, and Wim Ceelen. 2018. “Preclinical Activity of Two Paclitaxel Nanoparticle Formulations after IP Administration in Ovarian Cancer Xenografts.” In Regional Cancer Therapies, 13th International Symposium, Abstracts.
Vancouver
1.
Carlier C, Hoorens A, De Clercq K, Giordano S, Morosi L, Davoli E, et al. Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts. In: Regional Cancer Therapies, 13th International symposium, Abstracts. 2018.
IEEE
[1]
C. Carlier et al., “Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts,” in Regional Cancer Therapies, 13th International symposium, Abstracts, Jacksonville, FL, USA, 2018.
@inproceedings{8553083,
  author       = {{Carlier, Charlotte and Hoorens, Anne and De Clercq, Kaat and Giordano, Silvia and Morosi, Lavinia and Davoli, Enrico and Van Dorpe, Jo and Vervaet, Chris and Vanhaecke, Frank and Ceelen, Wim}},
  booktitle    = {{Regional Cancer Therapies, 13th International symposium, Abstracts}},
  language     = {{eng}},
  location     = {{Jacksonville, FL, USA}},
  title        = {{Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts}},
  year         = {{2018}},
}